Lung Cancer Related News
The impact of socioeconomic status on lung cancer screening participation
A new study demonstrates the benefits of lung cancer screening across socioeconomic groups and the importance of screening for people experiencing economic deprivation.
Lung cancer...
NHS pilot trials lung cancer blood test across thousands of patients
The NHS is conducting trials for a groundbreaking lung cancer blood test to detect the disease at its earliest stages.
Defence Therapeutics’ breakthrough in cancer treatment: AccuTOX® shows promise against lung tumours
Defence Therapeutics has announced the successful testing of a new formulation of its ACCUM-002TM Dimer CDCA-SV40 against lung tumours.
Researchers discover the mechanism behind lung adenocarcinoma
Researchers have found the mechanism responsible for the development of cancer-associated fibroblasts which are essential to lung adenocarcinoma.
Lung adenocarcinoma is a common form of...
Defence Therapeutics begin toxicology study on intranasal AccutoxTM
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the start...
Tumour matrix profiling can predict the severity of lung cancers
Researchers have identified molecular profiles of the surrounding matrix of common lung cancers, which could help indicate which patients are likely to develop aggressive...
NICE approve mobocertinib to treat aggressive lung cancer
Around 100 people will benefit from mobocertinib, a new treatment for rare and aggressive lung cancer after NICE published its final guidance on recommending...
New cancer treatments made possible by genome research
Researchers from the University of Bern have outlined new cancer treatments against non-small cell lung cancer by analysing the ‘dark matter’ of the human...
How does air pollution trigger non-small cell lung cancer?
A new mechanism shows very small pollutant particles in the air may cause non-small cell lung cancer in non-smokers.
New research by scientists from Francis...
Lung cancer treatment stops cancer worsening for over two years
A life-extending lung cancer treatment is available on the NHS, which could benefit over 550 patients a year.
The revolutionary lung cancer treatment is called...
New NHS campaign raises awareness of lung cancer symptoms
Today marks World Lung Cancer Day, and the NHS is encouraging people with lung cancer symptoms to urgently visit their GP in their latest...
Lung cancer immunotherapy side effects prevented with genetic discovery
Scientists at Edith Cowan University have made a groundbreaking genetic discovery that may eliminate side effects from lung cancer immunotherapy.
Of all types of cancer, lung...
NHS lung cancer screening trucks provide early diagnosis for hundreds of people
The NHS has revealed that hundreds of people have received a potentially life-saving early diagnosis for lung cancer thanks to its mobile lung cancer...
Does smoking cigarettes lead to the development of lung cancer?
A new study looks at why many people smoking cigarettes do not develop lung cancer despite it being the main cause of the disease.
A...
Small cell lung cancer discovery could lead to new treatment
Scientists have discovered a way to halt the development of small cell lung cancer, and this could lead to new treatment options.
Small cell lung...
Over 600 people in England to benefit from new lung cancer treatment
Osimertinib (Tagrisso) is a new lung cancer treatment that will be used for non-small cell lung cancer (NSCLC) that has begun to spread. It...
AI could speed up lung cancer diagnosis by a year
Scientists have developed an Artificial Intelligence (AI) screening method that they say could detect signs of lung cancer on CT scans a year faster...
Stem-like T cells may enhance immunotherapy cancer treatment
A team of researchers has made a potentially groundbreaking discovery in cancer treatment, identifying that stem-like T cells may be proficient in fighting against...
Hope of alternative treatment for osimertinib-relapsed lung cancer patients
A combination treatment has proved effective in treating patients with lung cancer whose disease progressed after treatment with osimertinib.
The Janssen Pharmaceutical Companies of Johnson...
Choosing better lung cancer treatments with machine learning
Researchers say that machine learning could help guide healthcare workers’ treatment decisions for lung cancer patients after developing a model that is 71% more...